The RF RDN Ablation Catheter is a cutting-edge, FDA-designated “Breakthrough Device” and approved for NMPA’s Special Review Channel for Innovative Medical Devices. It revolutionizes renal denervation (RDN) technology by advancing from 1st to 3rd-generation designs, enabling continuous energy field ablation for more effective treatment. Designed to provide lifelong benefits to hypertension patients, this minimally invasive solution aims to deliver superior outcomes through a single procedure.